I recommend a three-part income strategy: WRB.PR.E baby bond, PSA.PR.H preferred, and CME Group for a blend of yield and growth. WRB.PR.E and PSA.PR.H offers 7%+ yields, trades at discounts, and provides strong credit quality but lacks income growth and inflation protection. CME delivers a 4%+ yield, 8–10% expected EPS growth, and benefits from volatility, offering inflation protection and capital appreciation potential.
WRB's premium growth, higher investment income, and disciplined underwriting could support results, while rising expenses may temper profitability.
Get a deeper insight into the potential performance of W.R. Berkley (WRB) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
W.R. Berkley (WRB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
W. R. Berkley's underwriting discipline, record investment income and AI gains support earnings, while global risks and competition remain headwinds.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
W.R. Berkley's underwriting discipline and specialty expertise could help sustain strong margins as insurance pricing softens.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
W.R. Berkley (WRB) reported earnings 30 days ago. What's next for the stock?